Concerns with Generic Medicine

Patients in India rely on the advice of unqualified medical shop sellers instead of doctors when buying medicines.

What is the difference between generic and branded medicines?

About	Branded drugs	Generic drugs
Definition	They are also called as the “Innovator drugs” and are at first available in the market as new chemical entities	It is a pharmaceutical drug that contains the same chemical substance as a drug that was originally protected by chemical patents
Trade name	Sold under the manufacturer’s name	Not sold under the manufacturer’s name
Affordability	High Cost	Low cost
Patent protection	Produced by a company which holds the patent	Available at the market by the pharma companies only after the patent protection period expires
Animal and clinical study	Essential to perform tests	Not required
Features	The company formulates the chemical composition and establishes the dosage, strength, efficacy, administration etc.	The active ingredients, dosage, efficacy and administration are exactly same as that in branded drug
Competition	Little competition as patent protected	Competition is heavy due to price variation

What are the challenges associated with generic medicines?

Deciding authority- The doctors don’t have the freedom to choose the brand of generic medicine for the patient, only salesperson decides the brand.
Unethical practices- There is a corrupt link between pharmaceutical companies and doctors who can be influenced to give in to unethical marketing and promotional offers or kick-backs.
Counterfeit marketing - Big pharma companies focus on profit rather than quality and promote their costly propaganda against generic medicines.

Hathi Committee in 1975 recommended for the gradual elimination of brand names.

Lack of accountability- There is no clarity about who will ensure the compliance to the quality standards of drugs.
NMC directive- National Medical Commission’s (NMC) notification asking registered medical practitioners to prescribe only generic medicines but was later suspended due to protests.
Poor quality- Unauthentic and sub-standard medicines stands at 4.5% and 3.4%, which will directly impact patients’ health.
Lack of essential medicine- Non essential medicines like vitamin tonics, cough syrup etc., are available in pharmacy but the rate of essential medicine is low.

Steps taken by India to promote Generic Drugs

Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)- It is implemented by Ministry of Chemicals and Fertilizers to provide quality generic medicines at affordable price.
Each batch of drug is tested at laboratories accredited by ‘National Accreditation Board for Testing and Calibration Laboratories (NABL).
Pharmaceuticals and Medical Devices Bureau of India- It procures medicines only from World Health Organization – Good Manufacturing Practices (WHO-GMP) certified suppliers.
Janaushadhi Sugam- It is a mobile application that provides information to public about location of Jan Aushadhi Kendra’s.
Free drug initiative- Implemented under National Health Mission (NHM), it aims to provide essential generic drugs free of cost in public health facilities.
National Pharmaceutical Pricing Authority – It fixes the ceiling price of Scheduled medicines specified in the Schedule-I (essential medicines) of the Drugs (Prices Control) Order, 2013.

What lies ahead?

Quality assurance- Government must ensure the quality of medicines produced, procured, and supplied through its Universal Health Coverage system as well as the private health-care network.
Periodic testing- The medicines that fail periodic quality test must be banned, with punitive action taken against manufactures.
Rules for generic drugs- Government should assure that the medicines in the markets are of standard quality, this would ensure confidence in doctors.
Proper monitoring- To ensure affordable medicines for all under Universal Health Care, free medicines and diagnostics are acceptable, but implementation needs to be monitored.
Promoting generic drugs nationally builds on the rich experience across states especially Rajasthan and Tamil Nadu who are pioneers in introducing generic drugs in public health system.

In India, annually, about 32 million people get pushed below poverty line because of expenditure on medical care.

Source:

Join Our Telegram

Haryana Job Quota

Southern Annular Mode (SAM)

India’s Indo-Pacific Oceans Initiative (IPOI) UPSC GS-2 INDO PACIFIC – IR/PSIR

20 Nov, 25
SHARE

India’s Indo-Pacific Oceans Initiative (IPOI) UPSC GS-2 INDO PACIFIC – IR/PSIR IPOI is India’s open, voluntary and non-treaty-based maritime initiative for building a free, open, inclusive and rules-based Indo-Pacific through practical cooperation. Why in News? India’s Indo-Pacific Oceans Ini

AI Impact Summit 2026 UPSC GS-3 S&T PT-MAINS

19 May, 26
SHARE

AI Impact Summit 2026 UPSC GS-3 S&T PT-MAINS The India-AI Impact Summit 2026 positioned India as a Global South leader by shifting global AI debate from only AI safety and regulation to AI for development, inclusion and real-world impact. Why in News? India hosted the India-AI Impact Summit 2026 at B

Hong Kong Convention for Safe Ship Recycling UPSC GS-3 ENVIRONMENT PT-MAINS

27 Jun, 25
SHARE

Hong Kong Convention for Safe Ship Recycling UPSC GS-3 ENVIRONMENT PT-MAINS The Hong Kong International Convention, 2009 is an IMO treaty that ensures ships are recycled safely without unnecessary risk to human health, worker safety and the environment. Why in News? The Hong Kong Convention entered into force on 26 June 2

LeadIT 2.0: Leadership Group for Industry Transition COP28 UPSC GS-2 IR GS-3 S&T

14 Nov, 23
SHARE

LeadIT 2.0: Leadership Group for Industry Transition UPSC GS-2 IR GS-3 S&T LeadIT 2.0 is the second phase of the India-Sweden-led global initiative to support low-carbon transition in hard-to-abate industrial sectors. Why in News? The second phase of LeadIT was announced at the LeadIT Summit 2023, ho

India-EFTA Trade and Economic Partnership Agreement UPSC GS-2 IR/PSIR

03 Sep, 25
SHARE

India-EFTA Trade and Economic Partnership Agreement UPSC GS-2 IR/PSIR The India-EFTA TEPA is a comprehensive trade pact between India and four non-EU European countries — Iceland, Liechtenstein, Norway and Switzerland — aimed at boosting trade, investment, jobs, services, technology and supply-chain resilience. Wh